Alex Meraz Profile picture
23 Oct, 13 tweets, 12 min read
Fluid overload is bad news for patients:
1. Causes AKI
2. Prevents organ and patient recovery
3. Increases mortality

Ill share some of the data masterfully presented by @criticalbeansmd today at #KidneyWk starting with the take home points, in case this is the only tweet you see
Fluid Overload is very common, is all over the place and it has several definitios.

Patients accumulate weight at least for the first 7 days if the ICU doesn’t have some sort of FLUID STEWARDSHIP program in place. Remember fluids are drugs #KidneyWk.
There is no single situation in which Fluid overload is beneficial for patients. On the contrary. It is bad in every situation, doesnt matter how we slice or present the data. Liberal fluid strategies are always worse #KidneyWk
New meatanalisis on fluid overload of hundreds of papers. Look at the RR for mortality!!!! #kidneywk
In #AKI Fluid Overload is terrible!!! I have some news for you, Kidneys dont like extra fluid either. Say no to “permissive hypervolemia” Waiting for FO to be > 10% increases the risk of mortality by 2 fold. More FO and more time being FO, the higher risk of death. #KidneyWk
Several studies have shown that fluid overload dont correlate with fluid overload. However this remains an association. So, which are the potential mechanisms?
Some important concepts:
1. BP is not equal to flow
2. Our goal is organ perfussion
#KidneyWk
Fluid goes everywhere causing organ disfunction (gut, liver, skkin, brain, lung, heat, you name it) and no, we cannot infinite “third space”. Venous congestion directly opposes perfusion by impairing capillary drainage. #Kidneywk
Vol. overload causes all sorts of badness in the beans. I like to summarize them as: Nephrosarca. The picture is consistent with hemodynamic (formerly prerrenal) AKI. It can be misinterpreted as “extravascular volume expanded but intravascular volume depleted” 😵 #KidneyWk
Intraabdominal hypertension also causes organ disfunction, mainly in the kidneys worsening the whole picture. Half of the patients in ICU have IA hypertension and 20% abdominal compartamental syndrome #Kidneywk
Organ recovery requires organ perfussion. We need to decongest these patients. The FACTT trial showe us that it feasible to manage patient with only the amount of fluid that is necessary with better outcomes. No more “swell to get well” #Kidneywk
“Pee to be free (from the ICU)” Truer words have never been spoken. The best approach to fluid managment has not being elucidated. I would argue that prevention is the way to go. Knowing is half the battle. #Kidneywk
When is the best time for evacuating the extra fluid or how aggressive should we do it? We dont know... yet. Prevention is the first step. FLUID STEWARDSHIP people. Use your vasopressors early and wisely. Yes you can use them with diuretics #diuresisJedi #Kidneywk
Conclusion slide. Amazing talk. #Kidneywk

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Alex Meraz

Alex Meraz Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @NephroGuy

23 Oct
All nephrologists should be learning #POCUS now. It is safe, reproducible, cheap!!! Some uses are:
1. Rule out obstruction
2. Dx cause of hemodynamic inestability
3. To guide vascular access

@WBeaubien #KidneyWk
Beyon the basic applications in #AKI
1. Assessment of kidney perfussion
2. Detection of early AKI
3. Prediction ofpersistent AKI
4. Detect kidney congestion

2D US is ok, but using other modalities like doppler we can get more granular data on kidney hemodynamics.

#kidneywk
However using only color doppler or power doppler is not good enough. #KidneyWk
Read 9 tweets
23 Oct
#EmperorReduced. Patients enrolled with eGFR as low as 20 ml/min #Kidneywk
Impresive MAKEreduction #kidenywk
Results of EMPEROR #Kidneywk
Read 7 tweets
23 Oct
#Fidelio is now being presented #Kidenywk
Finerenone reduces decline of GFR and key secondary outcomes. Hyperkalemia was not really an issue #Kidneywk
Very safe drug in a trial context. Less hyperK than with spironolactone #kidneywk
Read 6 tweets
23 Oct
PetervRatcliffe presenting Homer W. Simith State of the Art Lecture. #KidneyWk
Rejected by @nature once, but he did’t falter. Which reminds me that success is never a straight line #KidneyWk
VHL was key for his work, the missing link if you will. #KidneyWk
Read 6 tweets
22 Oct
🚬Smoking increases 10x the risk of ESKD in #IgAN #Kidneywk Image
Steroids are no walk in the park in #IgAN. With very good supporting care loss of kidney function is very mild (-1.6 ml/min/year). Testing had to be terminated prematurely due to adverse events. #KidneyWk ImageImage
10 year follow up of #STOPIgA. No differences. And now with #SGLT2i or hydroxichloroquine thess curves may separate without the use of steroids. #KidneyWk Image
Read 4 tweets
22 Oct
Dr. Jardine on side effects of SGLT2i. Where is evidence coming from? #Kidneywk
Mostly is coming from CREDECE since it has the largest population of advanced CKD. Side effects are not different across different stages of CKD #Kidneywk
Hypoglycaemia not common, about 1%. DKA is rare (1 case per 1000 users) but real mostly seen in people who require insulin. #kidneywk
Read 13 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!